← Scroll for more →
Financial Statements — CCXIW
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | 1.25 | 0.41 | 0.74 |
| Total Current Assets | 1.61 | 0.79 | 1.06 |
| Total Non-current Assets* | 421.02 | 418.31 | 414.85 |
| Total Assets | 422.64 | 419.11 | 415.91 |
| Total Current Liabilities | 139.87 | 0.16 | 0.13 |
| Total Non-current Liabilities* | 14.49 | 15.99 | 15.99 |
| Total Liabilities | 154.36 | 16.15 | 16.12 |
| Retained Earnings | (152.60) | (14.14) | (14.21) |
| Total Stockholder Equity | (152.60) | (14.13) | (14.21) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Selling, General & Admin | 0.69 | 0.37 |
| Operating Income | (39.77) | (0.37) |
| Net Income | (134.68) | 3.17 |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | (0.16) | (0.33) |
| Capital Expenditures | 1.00 | -- |
| Free Cash Flow* | (1.16) | -- |
| Investing Cash Flow | 1.00 | -- |
← Scroll for more columns →
* Derived from reported values